• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Izafe Group

0.34 SEK+1.51 %31.7, 17.29
Less than 1K followers

IZAFE B

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+1.51 %
-11.08 %
-10.85 %
-24.61 %
-29.79 %
+12.33 %
+68.50 %
-82.84 %
-90.29 %

iZafe Group is a Life Science company focused on the development and marketing of digital medical solutions for home medication management. The company offers, among other things, a medication robot, SaaS solutions and a connected dosing bag. The products aim to reduce the risk of medication errors. Customers include individuals, pharmaceutical companies and public and private healthcare providers globally. iZafe Group is headquartered in Stockholm.

Read more
Market cap
148.61M SEK
Turnover
167.21K SEK
Revenue
5.99M
EBIT %
-280.14 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
1.9
2026

Interim report Q2'26

3.11
2026

Interim report Q3'26

16.2
2027

Annual report '26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release31.07.2026, 20.30

iZafe Group AB has carried out a directed set-off issue of B shares as partial payment for the acquisition of its Dutch subsidiary

Izafe Group
Regulatory press release10.07.2026, 14.00

iZafe Group AB carries out the first partial payment for the acquisition of its Dutch subsidiary through a set-off issue of B shares

Izafe Group
Press release07.07.2026, 08.45

June monthly letter – strong pipeline and preparations for an intensive autumn

Izafe Group

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release26.06.2026, 14.30

iZafe Group’s CEO transfers shares privately to enable participation in LTIP 2026:I

Izafe Group
Press release08.06.2026, 12.00

May monthly letter: continued scaling and increased utilisation

Izafe Group
Press release08.05.2026, 13.30

Monthly Letter April – Increased Activity and Growing Implementations

Izafe Group
Regulatory press release28.04.2026, 08.30

iZafe Group Q1 Interim Report, January-March 2026

Izafe Group
Press release23.04.2026, 08.30

Dosell awarded contract with Västervik Municipality regarding medication dispensing devices

Izafe Group
Press release13.04.2026, 11.00

iZafe Group Achieves ISO/IEC 27001 Certification and Strengthens Its Position for International Expansion

Izafe Group
Press release10.04.2026, 08.30

Monthly Update March – ADDA in effect and preparations for the next growth phase

Izafe Group
Press release07.04.2026, 08.30

Dosell AB awarded contract with Region Jönköping County and its municipalities

Izafe Group
Press release01.04.2026, 09.00

Dosell AB Granted European Patent in Data-Driven Medication Management

Izafe Group
Press release12.03.2026, 16.00

Dosell AB signs framework agreement with Adda following the end of the appeal period

Izafe Group
Regulatory press release12.03.2026, 15.00

Communiqué from the Extraordinary General Meeting of iZafe Group AB

Izafe Group
Press release09.03.2026, 09.00

Monthly Letter February – ADDA, Growth Capital and Preparations for Scaling

Izafe Group
Press release26.02.2026, 16.10

Dosell Awarded Framework Agreement in Sweden’s First National Procurement of Medication Dispensing Systems

Izafe Group
Regulatory press release19.02.2026, 08.40

iZafe Group AB has resolved on a directed share issue of class B shares of approximately SEK 19.8 million in order to accelerate the pace of sales and installations.

Izafe Group
Regulatory press release16.02.2026, 08.30

iZafe Group’s Quarterly Report Q4, October–December 2025

Izafe Group
Press release10.02.2026, 09.00

Monthly Update January – Broad Momentum and the Launch of a New Platform

Izafe Group
Press release21.01.2026, 09.00

iZafe Group launches modular Display and remote care system – one Dosell for all users

Izafe Group